Stay updated on Remdesivir Efficacy in Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Remdesivir Efficacy in Severe COVID-19 Clinical Trial page.

Latest updates to the Remdesivir Efficacy in Severe COVID-19 Clinical Trial page
- CheckyesterdayChange DetectedA site-wide funding-status notice was added and the page version updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check8 days agoChange DetectedAdded: Show glossary option; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Removed/altered: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page shows Revision: v3.3.4 where previously v3.3.3 appeared.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded a dedicated Locations section featuring Beijing Municipality as a location. The previous 'Beijing Municipality Locations' entry was removed.SummaryDifference0.2%

- Check72 days agoChange DetectedThese updates are minor editorial notes about how PubMed publications are displayed and include a page revision tag; they do not affect core study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedRemoved the government funding lapse notice related to operating status; no other substantive trial details appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Remdesivir Efficacy in Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Remdesivir Efficacy in Severe COVID-19 Clinical Trial page.